PARIS (Reuters) - Sanofi on Tuesday announced it had reached an agreement with Janssen, a part of Johnson & Johnson, to develop and commercialize a vaccine candidate for extra-intestinal pathogenic E.coli. Under the terms of the deal, both parties will co-fund current and future research and development costs.
Sanofi in agreement with Janssen to develop E. coli the vaccine candidate
PARIS (Reuters) - Sanofi on Tuesday announced it had reached an agreement with Janssen... ..
Multipostit B2
Publié 7 mois depuis
18 Vues
actualisé 7 mois depuis
Multipostit B2
Homme , Lives in France
Source et suite : www.challenges.fr
Votre réaction?
LOL
LOVED
PURE
AW
FUNNY
BAD!
EEW
OMG!
ANGRY